| Literature DB >> 34851462 |
Francesco Oliva1,2, Filippo Migliorini3, Francesco Cuozzo1, Ernesto Torsiello1, Frank Hildebrand4, Nicola Maffulli1,5,6.
Abstract
BACKGROUND: The reamer irrigator aspirator (RIA) is a relatively recent device that is placed in the medullary canal of long bones to harvest a large volume of bone marrow, which is collected in a filtered canister. This study compares outcomes and complications of the RIA versus a traditional iliac crest bone graft (ICBG) for the treatment of bone defects.Entities:
Keywords: Aspirator; Autologous; Bone; Crest; Graft; ICBG; Iliac; Irrigator; Nonunion; RIA; Reamer
Mesh:
Year: 2021 PMID: 34851462 PMCID: PMC8636545 DOI: 10.1186/s10195-021-00612-9
Source DB: PubMed Journal: J Orthop Traumatol ISSN: 1590-9921
Fig. 1Flow chart of the literature search
Methodological quality assessment
| Authors, year | Part A: Only one score to be given for each of the seven sections | Part B: Scores may be given for each option in each of the three sections if applicable | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study size | Mean follow-up | Surgical approach | Type of study | Description of diagnosis | Description of surgical technique | Description of postoperative rehabilitation | Outcome criteria | Procedure used to assess outcomes | Description of subject selection process | |||||||||
| Outcome measures clearly defined | Timing of outcome assessment clearly stated | Use of outcome criteria that have reported reliability | General health measure included | Participants recruited | Investigator independent of surgeon | Written assessment | Completion of assessment by patients themselves with minimal investigator assistance | Selection criteria are reported and unbiased | Reported recruitment rate > 80% | Reported recruitment rate < 80% | ||||||||
| Alhmann et al., 2002 [ | 7 | 7 | 7 | 10 | 5 | 5 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Almaiman et al., 2013 [ | 10 | 4 | 10 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Banwart et al., 1995 [ | 10 | 10 | 10 | 0 | 5 | 5 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Belthur et al., 2008 [ | 7 | 4 | 7 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 3 | 3 | 5 | 5 | 0 |
| Beirne et al., 1996 [ | 10 | 4 | 10 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Burstein et al., 2000 [ | 7 | 4 | 10 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Calori et al., 2014 [ | 4 | 0 | 7 | 0 | 5 | 5 | 5 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Carlock et al., 2019 [ | 10 | 4 | 10 | 0 | 5 | 5 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 3 | 3 | 5 | 5 | 0 |
| Conway et al., 2014 [ | 0 | 0 | 10 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| David et al., 2003 [ | 10 | 4 | 10 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 3 | 3 | 5 | 5 | 0 |
| Dawson et al., 2014 [ | 10 | 7 | 7 | 15 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Delawi et al., 2007 [ | 7 | 10 | 10 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Deorio et al., 2005 [ | 10 | 10 | 10 | 0 | 5 | 10 | 5 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Dimar et al., 2009 [ | 10 | 4 | 10 | 0 | 5 | 5 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Fernyhough et al., 1992 [ | 10 | 4 | 10 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Finkemeir et al., 2010 [ | 4 | 4 | 10 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Goulet et al., 1997 [ | 10 | 7 | 10 | 0 | 5 | 5 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 3 | 3 | 5 | 5 | 0 |
| Han et al., 2015 [ | 7 | 7 | 10 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Haubruck et al., 2018 [ | 10 | 10 | 10 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 3 | 3 | 5 | 5 | 0 |
| Hill et al., 1999 [ | 7 | 7 | 10 | 0 | 5 | 5 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Kanakaris et al., 2011 [ | 4 | 0 | 10 | 10 | 5 | 5 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Kim et al., 2009 [ | 10 | 4 | 10 | 10 | 5 | 5 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Kusnezov et al., 2017 [ | 4 | 4 | 10 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Le Baron et al., 2019 [ | 7 | 7 | 7 | 10 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Loeffler et al., 2012 [ | 7 | 4 | 10 | 10 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Mccall et al., 2010 [ | 4 | 7 | 10 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Marchand et al., 2017 [ | 10 | 4 | 7 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Merrit et al., 2010 [ | 7 | 4 | 10 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Metsemakers et al., 2019 [ | 7 | 10 | 10 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 4 | 0 | 3 | 5 | 5 | 0 |
| Mirovski et al., 2000 [ | 7 | 4 | 7 | 10 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 3 | 3 | 5 | 5 | 0 |
| Nodzo et al., 2014 [ | 4 | 0 | 7 | 0 | 5 | 5 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| On Salawu et al., 2017 [ | 7 | 4 | 10 | 10 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 3 | 3 | 5 | 5 | 0 |
| Pollock et al., 2008 [ | 7 | 4 | 10 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Qvick et al., 2013 [ | 10 | 7 | 10 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Robertson et al., 2001 [ | 10 | 4 | 10 | 10 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 4 | 0 | 3 | 5 | 5 | 0 |
| Schizas et al., 2009 [ | 7 | 4 | 10 | 10 | 5 | 5 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Schwartz et al., 2009 [ | 10 | 7 | 10 | 10 | 5 | 5 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 3 | 3 | 5 | 5 | 0 |
| Silber et al., 2003 [ | 10 | 7 | 10 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Westrich et al., 2001 [ | 10 | 0 | 10 | 0 | 5 | 10 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
| Younger et al., 1989 [ | 10 | 0 | 10 | 0 | 5 | 5 | 0 | 2 | 2 | 3 | 3 | 5 | 0 | 0 | 3 | 5 | 5 | 0 |
Fig. 2Funnel plot
Generalities and patient baselines of the included studies
| Authors, year | Journal | Type of study | CMS | Follow-up (months) | Treatment | Patients ( | Mean age (years) | Female ( |
|---|---|---|---|---|---|---|---|---|
| Alhmann et al., 2002 [ | Retrospective | 67 | 60.0 | ICBG | 88 | 46.2 | 13 | |
| ICBG | ||||||||
| Almaiman et al., 2013 [ | Retrospective | 67 | 12.0 | ICBG | 372 | 172 | ||
| Banwart et al., 1995 [ | Retrospective | 68 | 66.0 | ICBG | 180 | 26.3 | 115 | |
| Belthur et al., 2008 [ | Retrospective | 64 | 9.1 | RIA | 41 | 44.9 | 18 | |
| 20.2 | ICBG | 40 | 46.4 | 17 | ||||
| Beirne et al., 1996 [ | Retrospective | 67 | 12.0 | ICBG | 137 | 60 | ||
| Burstein et al., 2000 [ | Retrospective | 60 | ICBG | 55 | 11.2 | 22 | ||
| Calori et al., 2014 [ | Retrospective | 54 | 12.0 | RIA | 35 | 50.17 | 12 | |
| ICBG | 35 | 53.62 | 14 | |||||
| Carlock et al., 2019 [ | Retrospective | 65 | 12.0 | ICBG | 242 | 58.3 | 107 | |
| Conway et al., 2014 [ | Retrospective | 51 | 6.5 | RIA | 7 | 45.0 | 3 | |
| David et al., 2003 [ | Retrospective | 70 | 26.5 | ICBG | 107 | 42.75 | 43 | |
| Dawson et al., 2014 [ | RCT | 82 | 56.9 | RIA | 56 | 41.3 | 23 | |
| ICBG | 57 | 47.4 | 22 | |||||
| Delawi et al., 2007 [ | Retrospective | 70 | 87.6 | ICBG | 71 | 47.6 | 22 | |
| Deorio et al., 2005 [ | Retrospective | 78 | 74.4 | ICBG | 134 | |||
| Dimar et al., 2009 [ | Retrospective | 62 | 24.0 | ICBG | 194 | 52.3 | ||
| Fernyhough et al., 1992 [ | Retrospective | 67 | 12.0 | ICBG | 147 | 50 | ||
| Finkemeir et al., 2010 [ | Retrospective | 61 | 18.0 | RIA | 23 | 50.0 | 10 | |
| Goulet et al., 1997 [ | Retrospective | 61 | ICBG | 170 | 41.0 | 60 | ||
| Han et al., 2015 [ | Retrospective | 67 | 54.0 | RIA | 57 | 3 | ||
| Haubruck et al., 2018 [ | Retrospective | 75 | 75.0 | RIA | 306 | 54.0 | 113 | |
| Hill et al., 1999 [ | Retrospective | 62 | 37.0 | ICBG | 73 | 38.0 | 31 | |
| Kanakaris et al., 2011 [ | Prospective | 62 | 6.0 | RIA | 42 | 45.5 | 14 | |
| Kim et al., 2009 [ | Prospective | 72 | 12.0 | ICBG | 110 | 50.4 | 56 | |
| Kusnezov et al., 2017 [ | Retrospective | 61 | 13.3 | RIA | 15 | 41.1 | 5 | |
| Le Baron et al., 2019 [ | Prospective | 74 | 22.1 | RIA | 30 | 38.9 | 9 | |
| 56.7 | ICBG | 29 | 35.3 | 6 | ||||
| Loeffler et al., 2012 [ | Prospective | 74 | 12.0 | ICBG | 92 | 31 | ||
| Mccall et al., 2010 [ | Prospective | 64 | 48.0 | RIA | 21 | 30.6 | 8 | |
| Marchand et al., 2017 [ | Retrospective | 62 | 13.0 | RIA | 61 | 51.0 | 50 | |
| ICBG | 47 | 54.0 | ||||||
| Merrit et al., 2010 [ | Retrospective | 64 | 24.0 | ICBG | 92 | 62.0 | 60 | |
| Metsemakers et al., 2019 [ | Retrospective | 72 | 84.0 | RIA | 72 | 45.4 | 23 | |
| Mirovski et al., 2000 [ | Prospective | 72 | 24.0 | ICBG | 60 | 39.8 | ||
| Nodzo et al., 2014 [ | Retrospective | 47 | RIA | 29 | 49.4 | 21 | ||
| ICBG | 27 | 49.3 | 21 | |||||
| On Salawu et al., 2017 [ | Prospective | 77 | 13.0 | ICBG | 86 | 40.8 | 33 | |
| Pollock et al., 2008 [ | Retrospective | 64 | 19.8 | ICBG | 77 | 46.1 | 47 | |
| Qvick et al., 2013 [ | Retrospective | 70 | 48.0 | RIA | 204 | 50.0 | 88 | |
| Robertson et al., 2001 [ | Prospective | 78 | 12.0 | ICBG | 106 | 47.4 | 72 | |
| Schizas et al., 2009 [ | Prospective | 69 | 36.0 | ICBG | 59 | |||
| Schwartz et al., 2009 [ | Prospective | 78 | 42.9 | ICBG | 170 | 51.1 | ||
| Silber et al., 2003 [ | Retrospective | 70 | 48.0 | ICBG | 134 | 75 | ||
| Westrich et al., 2001 [ | Retrospective | 63 | RIA | 390 | 47.9 | 183 | ||
| Younger et al., 1989 [ | Retrospective | 58 | 11.0 | ICBG | 239 | 33.0 | 86 |
RIA reamer irrigator aspirator, ICBG iliac crest bone graft, RCT randomized controlled trial
Patient baseline demographics of the included studies
| Endpoint | ICBG ( | RIA ( | |
|---|---|---|---|
| Mean age | 44.4 ± 10.9 | 45.7 ± 5.9 | 0.6 |
| Mean BMI | 27.9 ± 2.6 | 28.6 ± 3.3 | 0.8 |
| Harvest volume (mean) | 38.7 ± 15.7 | 47.6 ± 12.1 | 0.2 |
Comparison of VAS and mean time to union
| Endpoint | ICBG ( | RIA ( | MD | |
|---|---|---|---|---|
| VAS | 2.3 ± 1.5 | 1.7 ± 2.4 | 0.6 | 0.09 |
| Time to union (mean) | 11.5 ± 1.9 | 7.2 ± 1.6 | 4.3 | 0.06 |
Complications
| Endpoint | ICBG | RIA | OR | 95% CI | |
|---|---|---|---|---|---|
| Site pain | 38.7% (674 of 1742) | 4.6% (22 of 481) | 13.16 | 8.4926–20.4135 | < 0.0001 |
| Fracture | 1.0% (4 of 407) | 1.2% (7 of 567) | 0.79 | 0.2309–2.7306 | 0.7 |
| Infection | 5.0% (75 of 1493) | 1.8% (11 of 605) | 2.85 | 1.5060–5.4168 | 0.001 |
| Hematoma/seroma | 1.4% (17 of 1204) | 0.9% (4 of 462) | 1.63 | 0.5489–4.8995 | 0.4 |
| Union | 88.3% (477 of 540) | 81.6% (315 of 386) | 17.28 | 12.8770–23.1941 | < 0.0001 |
| Adverse event | 22.3% (327 of 1467) | 4.7% (12 of 255) | 5.80 | 3.2118–10.5048 | < 0.0001 |
Fig. 3Meta-analyses